General Information of the Compound
Compound ID
CP0549529
Compound Name
4-[6-[3-(5-methylpyrazol-1-yl)propoxy]pyrimidin-4-yl]-2-phenylmorpholine
    Show/Hide
Structure
Formula
C21H25N5O2
Molecular Weight
379.464
Canonical SMILES
Cc1ccnn1CCCOc1cc(ncn1)N1CCOC(C1)c1ccccc1
    Show/Hide
InChI
InChI=1S/C21H25N5O2/c1-17-8-9-24-26(17)10-5-12-28-21-14-20(22-16-23-21)25-11-13-27-19(15-25)18-6-3-2-4-7-18/h2-4,6-9,14,16,19H,5,10-13,15H2,1H3
    Show/Hide
InChIKey
MKQINUTWQAXTDS-UHFFFAOYSA-N
Physicochemical Property
logP
3.02852
Rotatable Bonds
7
Heavy Atom Count
28
Polar Areas
65.3
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166631388
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05231, Very long chain fatty acid elongase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 7 nM
   TI
   LI
   LO
   TS